Xtrem Biotech
-
DATABASE (56)
-
ARTICLES (44)
WWF-backed biotech Oceanium has developed a biorefinery that transforms seaweed into alt-proteins and compostable packaging that will soon be launched commercially.
WWF-backed biotech Oceanium has developed a biorefinery that transforms seaweed into alt-proteins and compostable packaging that will soon be launched commercially.
Biotech Bluepha has secured close to $100m Series B funding to boost bioplastics production and R&D to develop greener solutions for industrial manufacturers.
Biotech Bluepha has secured close to $100m Series B funding to boost bioplastics production and R&D to develop greener solutions for industrial manufacturers.
CEO and co-founder of String Bio
Ezhil Subbian studied industrial biotechnology at Anna University in India. She then went to the US to complete two PhDs in biochemistry, biophysics and molecular biology at the Oregon Health & Science University and from Rutgers, the State University of New Jersey-New Brunswick. She was a research assistant at both universities.While in the US, she was also a research scientist at Gevo Inc and at Vollum Institute. In 2008, she became a scientist and technical lead at pharma Codexis in California. In 2011, she worked at San Francisco-based Kumar Investments as an entrepreneur and biotech consultant.In 2012, she founded biotech startup String Inc while on a nine-month Startup Leadership Program in Silicon Valley. In June 2013, she and husband returned to India and formed a new company String Bio to continue working on the alternative protein powder project for animal feed production.
Ezhil Subbian studied industrial biotechnology at Anna University in India. She then went to the US to complete two PhDs in biochemistry, biophysics and molecular biology at the Oregon Health & Science University and from Rutgers, the State University of New Jersey-New Brunswick. She was a research assistant at both universities.While in the US, she was also a research scientist at Gevo Inc and at Vollum Institute. In 2008, she became a scientist and technical lead at pharma Codexis in California. In 2011, she worked at San Francisco-based Kumar Investments as an entrepreneur and biotech consultant.In 2012, she founded biotech startup String Inc while on a nine-month Startup Leadership Program in Silicon Valley. In June 2013, she and husband returned to India and formed a new company String Bio to continue working on the alternative protein powder project for animal feed production.
New York-based Humboldt Fund invests in startups with the potential to solve critical issues of our time across the areas of food production, healthcare, energy, and construction and manufacturing materials. It currently has 14 companies in its portfolio. Its most recent investments include in the March 2021 $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech, and in the February 2021 $16m seed round of US biotech Cellino Biotech.
New York-based Humboldt Fund invests in startups with the potential to solve critical issues of our time across the areas of food production, healthcare, energy, and construction and manufacturing materials. It currently has 14 companies in its portfolio. Its most recent investments include in the March 2021 $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech, and in the February 2021 $16m seed round of US biotech Cellino Biotech.
Founded in 2011, the knowledge capital fund is an initiative from the InKemia IUCT Group to focus on innovation and the licensing of patents in the biotech sectors. InKemia supports the life science industry through R&D grant programs, technical consultancy and training. It specializes in areas such as chemical synthesis, biotech, bio-catalysis, quality control and EU releases of new products. InKemia also supports local entrepreneurs through the Manuel Arroyo Award for Young Entrepreneurs with the aim to promote local cooperative economic development.
Founded in 2011, the knowledge capital fund is an initiative from the InKemia IUCT Group to focus on innovation and the licensing of patents in the biotech sectors. InKemia supports the life science industry through R&D grant programs, technical consultancy and training. It specializes in areas such as chemical synthesis, biotech, bio-catalysis, quality control and EU releases of new products. InKemia also supports local entrepreneurs through the Manuel Arroyo Award for Young Entrepreneurs with the aim to promote local cooperative economic development.
Jeffrey Leiden is a physician and scientist of more than 40 years, who is currently the executive chairman of US-based multinational biotech company Vertex Pharmaceuticals. Leiden is also the chairman of Casana, a remote healthcare platform and the chairman of Tmunity, a biotech dedicated to T-cell research. In March 2021, he participated as an angel investor in the $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech.
Jeffrey Leiden is a physician and scientist of more than 40 years, who is currently the executive chairman of US-based multinational biotech company Vertex Pharmaceuticals. Leiden is also the chairman of Casana, a remote healthcare platform and the chairman of Tmunity, a biotech dedicated to T-cell research. In March 2021, he participated as an angel investor in the $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech.
Co-founder, CTO of Polaroo
Sergio Sanchez is the CTO and co-founder of Widuid that was later re-branded as Polaroo, a Spanish household bill management app. He spent eight months working on building the MVP with the Rovira brothers in 2017.The mechanical engineer also completed a master's in Automatic Control and Robotics at his alma mater, the Polytechnic Degree of Barcelona. Like fellow co-founder Marc Rovira, Sanchez was also at space tech startup Zero2Infinity working as a full stack developer and HMI engineer. He has also worked in biotech company Fungitech Global as a mechanical engineer.
Sergio Sanchez is the CTO and co-founder of Widuid that was later re-branded as Polaroo, a Spanish household bill management app. He spent eight months working on building the MVP with the Rovira brothers in 2017.The mechanical engineer also completed a master's in Automatic Control and Robotics at his alma mater, the Polytechnic Degree of Barcelona. Like fellow co-founder Marc Rovira, Sanchez was also at space tech startup Zero2Infinity working as a full stack developer and HMI engineer. He has also worked in biotech company Fungitech Global as a mechanical engineer.
Karnataka Information and Biotechnology Venture Fund (KITVEN)
Founded in 1999, KITVEN is a state investor in startups in the Indian state of Karnataka. Major investment sectors include biotech, animation, visual effects, electronics, manufacturing, gaming and comics. Based in Bengaluru, the office is run by Karnataka Asset Management Company Private Limited.KITVEN has invested in more than 50 startups. In 2019, the VC invested in String Bio’s Series A round and joined the $2.2m seed round of smart lock startup Open App. Backed by state and central government financial institutions, the VC manages five funds: KITVEN Fund, KITVEN Fund 2, KITVEN Fund 3 Biotech, KITVEN Fund 4 and Karnataka Semiconductor Venture Capital Fund (KARSEMVEN Fund).
Founded in 1999, KITVEN is a state investor in startups in the Indian state of Karnataka. Major investment sectors include biotech, animation, visual effects, electronics, manufacturing, gaming and comics. Based in Bengaluru, the office is run by Karnataka Asset Management Company Private Limited.KITVEN has invested in more than 50 startups. In 2019, the VC invested in String Bio’s Series A round and joined the $2.2m seed round of smart lock startup Open App. Backed by state and central government financial institutions, the VC manages five funds: KITVEN Fund, KITVEN Fund 2, KITVEN Fund 3 Biotech, KITVEN Fund 4 and Karnataka Semiconductor Venture Capital Fund (KARSEMVEN Fund).
One of the earliest VC/PE firms in China, Shenzhen GTJA Investment focuses on the healthcare/biotech industry. It manages about RMB 10 billion and has invested in more than 100 companies since its inception in 2001.
One of the earliest VC/PE firms in China, Shenzhen GTJA Investment focuses on the healthcare/biotech industry. It manages about RMB 10 billion and has invested in more than 100 companies since its inception in 2001.
CEO and co-founder of Because Animals
Shannon Falconer graduated with a master’s in botany at the University of Vancouver in 2006. She also completed a PhD in biochemistry at The McMaster University in 2014. She went on to work as a postdoctoral researcher at Stanford University until 2016 when she decided to become the CEO and co-founder of biotech startup Because Animals. She also led the biotech’s R&D team to develop plant-based nutritional cookies and treats for dog and cats. Because Animals now aims to produce the world’s first cell-based cultured meat products for pets.
Shannon Falconer graduated with a master’s in botany at the University of Vancouver in 2006. She also completed a PhD in biochemistry at The McMaster University in 2014. She went on to work as a postdoctoral researcher at Stanford University until 2016 when she decided to become the CEO and co-founder of biotech startup Because Animals. She also led the biotech’s R&D team to develop plant-based nutritional cookies and treats for dog and cats. Because Animals now aims to produce the world’s first cell-based cultured meat products for pets.
DSM Venturing is the investment arm of major Dutch biotech company DSM that has been investing in startups since 2006. The company currently has 36 startups in its portfolio across geographies and has managed three exits to date. It typically invests between €100,000 and €5m, with a lifetime investment varying from €1m–20m and usually requires board membership alongside investment. It has offices in the Netherlands and the US, both on the east and west coast. Its recent investments include in the March 2021 $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech, and in the same month, in the $8m Series A round of British anti-pollution biotech Deep Branch Biotechnology.
DSM Venturing is the investment arm of major Dutch biotech company DSM that has been investing in startups since 2006. The company currently has 36 startups in its portfolio across geographies and has managed three exits to date. It typically invests between €100,000 and €5m, with a lifetime investment varying from €1m–20m and usually requires board membership alongside investment. It has offices in the Netherlands and the US, both on the east and west coast. Its recent investments include in the March 2021 $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech, and in the same month, in the $8m Series A round of British anti-pollution biotech Deep Branch Biotechnology.
Green Innovations is an impact fund that invests in large-scale projects addressing global sustainability challenges, focusing on the agriculture, biotechnology, education, energy, housing and water sectors. It is headed by Angola-based Portuguese businessman Jorge Marques, and linked to Israeli group Mitrelli. Green Innovations took control of Biocant, Portugal’s biggest biotech park, in a privatization move in 2017–2018. Green Innovations's stable of companies includes Green Biotech, created to invest in biotechnology in Portugal, and Green Services Innovations, linked to the exploration of phosphates in Congo.Its recent investments include in the June 2021 $85m Series C round and February 2021 $25m Series B of Portuguese home physiotherapy tech solution SWORD Health, the world’s fastest-growing musculoskeletal solution.
Green Innovations is an impact fund that invests in large-scale projects addressing global sustainability challenges, focusing on the agriculture, biotechnology, education, energy, housing and water sectors. It is headed by Angola-based Portuguese businessman Jorge Marques, and linked to Israeli group Mitrelli. Green Innovations took control of Biocant, Portugal’s biggest biotech park, in a privatization move in 2017–2018. Green Innovations's stable of companies includes Green Biotech, created to invest in biotechnology in Portugal, and Green Services Innovations, linked to the exploration of phosphates in Congo.Its recent investments include in the June 2021 $85m Series C round and February 2021 $25m Series B of Portuguese home physiotherapy tech solution SWORD Health, the world’s fastest-growing musculoskeletal solution.
CEO and co-founder of Zipline International
After graduating in economics and biotech at Harvard in 2009, Keller Rinaudo joined BCG in San Francisco but left to become a professional rock climber in November 2010. He has climbed alpine cliffs in France, underwater caves in Kentucky and the limestone towers of Yangshuo, China.In July 2011, Rinaudo became an entrepreneur, specializing robotics and drones, with over nine patents under his name. He founded Romotive that made inexpensive small robots using mobile phones as their computing system, machine vision system and wireless communication system.Romotive was pivoted into Zipline International in 2014 to design and manufacture make drones for the delivery of critical medical supplies in remote parts of the world.
After graduating in economics and biotech at Harvard in 2009, Keller Rinaudo joined BCG in San Francisco but left to become a professional rock climber in November 2010. He has climbed alpine cliffs in France, underwater caves in Kentucky and the limestone towers of Yangshuo, China.In July 2011, Rinaudo became an entrepreneur, specializing robotics and drones, with over nine patents under his name. He founded Romotive that made inexpensive small robots using mobile phones as their computing system, machine vision system and wireless communication system.Romotive was pivoted into Zipline International in 2014 to design and manufacture make drones for the delivery of critical medical supplies in remote parts of the world.
Founded in 2013 in Singapore, VVNP is a future-food solutions-orientated investor with a special interest in science-based companies that have the ability to scale global solutions, especially within Asia. It invests from seed stage to Series C level. Typical investments range from $300,000 to $3m and the investor has launched two funds to date. The first raised $40m and invested in seven companies globally, while the second was created in 2020, targeting $150m in total investment.The VC’s most recent investments include a €271,000 pre-seed investment round in Dutch poultry animal welfare biotech In Ovo in March 2021, and leading the as-yet-uncompleted 6m Swiss franc (approximately $6.56m) seed round in Swiss biotech SwissDeCode in January 2021 – a company that applies DNA testing to food traceability.
Founded in 2013 in Singapore, VVNP is a future-food solutions-orientated investor with a special interest in science-based companies that have the ability to scale global solutions, especially within Asia. It invests from seed stage to Series C level. Typical investments range from $300,000 to $3m and the investor has launched two funds to date. The first raised $40m and invested in seven companies globally, while the second was created in 2020, targeting $150m in total investment.The VC’s most recent investments include a €271,000 pre-seed investment round in Dutch poultry animal welfare biotech In Ovo in March 2021, and leading the as-yet-uncompleted 6m Swiss franc (approximately $6.56m) seed round in Swiss biotech SwissDeCode in January 2021 – a company that applies DNA testing to food traceability.
Yueyin Venture Capital was founded in 2015 in Beijing. It manages total assets worth US$300m, with investments in 22 companies. The VC focuses mainly in the healthcare, pharmaceutical and biotech sectors.
Yueyin Venture Capital was founded in 2015 in Beijing. It manages total assets worth US$300m, with investments in 22 companies. The VC focuses mainly in the healthcare, pharmaceutical and biotech sectors.
Xtrem Biotech, an agritech startup from Granada, seeks global expansion
With its research roots in the University of Granada, Xtrem Biotech was named one of the world's most innovative agtech spin-offs by accelerator TERRA Food & AgTech
Daniel Oliver: Building a "Facebook" for investments in biotech startups
The biologist and crowdfunding expert has pioneered the growth of Spanish biotech startups, providing access to early-stage investments, with support from scientific experts worldwide
Meatable: Cell-based meat startup secures $47m Series A for scalable technology
The Dutch startup offers a pioneering technology for quickly scaling cell-based meat production while eliminating the need for animal-derived growth media
Forget solar panels and batteries, Bioo wants to scale soil bioelectricity generation
Improving on NASA’s microbial fuel cell tech, Bioo hopes to boost crop efficiency and transform the way urbanites live, in future green cities powered by plants
TurtleTree Labs: Creating sustainable mammalian milk alternatives from stem cells
Founder’s search for high-quality dairy milk led to the creation in a lab of naturally occurring ingredients found in human milk for supply to dairy milk and infant formula businesses
Sequoia Capital China holds steady with investments in healthcare, biotech and green economy
China’s most active investor increases bets on sectors beyond the consumer internet and edtech recently hurt by regulatory clampdown
Because Animals: Pioneering cultured meat for pets
The biotech startup is disrupting the pet food processing industry with cell-based food to minimize environmental “pawprints” and promote animal welfare
NovoNutrients: Tackling the dual problems of CO2 emissions and over-fishing
The first to transform CO2 to fish food, NovoNutrients is trialing with industry giants Skretting and Chevron, and will soon raise Series A funding
Poliloop: Tackling pollution crisis with plastic-eating bacteria for industrial use
Hungarian biotech Poliloop is closing $2m seed funding for “bacteria cocktail” that breaks down plastic into organic waste quickly, enabling more affordable and eco-friendly waste management
Qorium: Lab-grown premium leather for the future of luxury
The Dutch biotech startup co-founded by cell-based meat pioneer Mark Post is targeting the luxury goods market with its “clean leather” sheets made from cultivating bovine skin cells, and plans to raise up to €100m
Mycorena: Fungi-based vegan protein challenging traditional plant-based ingredients
Award-winning Swedish biotech startup is scaling production of mycoprotein to become a key player in the emerging market for functional proteins
TreeFrog Therapeutics: Mimicking how stem cells grow in the human body
The French biotech’s proprietory technology to cultivate pluripotent stem cells in a 3D environment can be scaled to mass-produce high-quality cells to treat diseases such as Parkinson’s
New Food Invest: Opportunities in the European alt-protein space
With a record €2.4bn investment in 2019, Europe’s foodtech sector appears poised for continued growth, but startups, corporations, governments and even universities can do more, experts say
Future Food Asia by ID Capital: Introducing Asia's agrifood startups to the world
More than a meeting of startups and investors, the conference showcases ID Capital’s investment thesis and Big Ag’s support for agrifood tech in the world’s most populous region
Cubiq Foods: Bioreactor farms producing the food of tomorrow
Growing appetite for meat alternatives expected to fuel demand for Cubiq’s low calorie, Omega 3-enriched lab-grown fats
Sorry, we couldn’t find any matches for“Xtrem Biotech”.
POPULAR DATABASE
